TARO-RIVAROXABAN
TARO-RIVAROXABAN
Approved
DIN Number
02526786
Drug Class
Human
Market Date
Nov 1, 2023
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526786
AIG Number0152487004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF01 RIVAROXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIVAROXABANActive
Strength: 2.5 MG
Monograph: RIVAROXABAN